home > People > Li Guocong

PHONE

18931159083

LANGUAGE

Chinese

English

Li Guocong

Partner of DHH Shijiazhuang Office/Director of Intellectual Property Business Unit

liguocong@deheng.com

Work Experience: 
 
From 2005 to 2013, Shiyao Group Ouyi Pharmaceutical Co., Ltd., intellectual property department manager, marketing department manager. 
From 2013 to 2019, Hebei Dongshang Law Firm, practicing lawyer and practicing patent agent. 
Since 2019, Beijing DHH (Shijiazhuang) Law Firm, practicing lawyer, practicing patent agent. 
 
Introduction:
 
Li Guocong, a lawyer, has graduated from Hebei Medical University and Peking University with a bachelor's degree in pharmaceutical preparation science and a master's degree in international pharmaceutical engineering management, respectively. Since 2006, he has been engaged in the creation, protection, application and management of intellectual property rights. He has been responsible for intellectual property protection, intellectual property litigation and other work in large pharmaceutical enterprises. He has in-depth research and rich practical experience in intellectual property rights, companies, anti-unfair competition, food and drug (medical devices) and other laws and regulations, and has formed a multi-level and multi-faceted intellectual property legal service product. Be able to provide decision-making compliance legal risk prevention, intellectual property protection planning, intellectual property use compliance risk management and control, intellectual property due diligence, intellectual property infringement litigation, trade secret protection and other businesses for national market regulatory authorities, enterprises and public institutions, and social groups. He is currently a member of China Law Association, a member of the Professional Committee of Intellectual Property Law of Hebei Lawyers Association, an expert in the expert pool of Hebei Intellectual Property Rights Protection Assistance Center, a member of Hebei Intellectual Property Protection and Development Association, and a member of the Professional Committee of Intellectual Property Rights of Shijiazhuang Lawyers Association.
 
[Representative Cases] 
 
(1) To represent more than 300 cases of intellectual property rights (patents, copyrights, trademarks, etc.). 
(2) The case of dispute over infringement of the patent right for invention on behalf of a well-known antihypertensive drug has gone through the procedures of first instance of the Intermediate People's Court, second instance of the Higher People's Court, appeal of the Supreme People's Court, and invalidation of the Patent Re-examination Board. 
(3) A case in which a mechanical manufacturing company is requested to investigate and punish a dispute over the suspected infringement of several utility model patent rights. 
(4) Case on Protection of Patent Infringement Rights of Moxibustion Box Utility Model of Medical Devices as an Agent. 
(5) The case of a dispute over the alleged infringement of the patent right for invention by a well-known antibiotic enteric-coated preparation product as an agent is requested to be investigated and punished. 
(6) A case of infringement of the patent right for the utility model of the new sand bagging machine and invalidity of the patent right for the utility model filed by a company on behalf of a company. 
(7) A case of acting as an agent for the patent right for a crystalline invention of a compound suspected of being infringed upon to request administrative mediation for rights protection. 
(8) Providing legal opinions on the research and development direction and patent protection layout of hemodialysis products in a research institute. 
(9) Legal opinions on the intellectual property protection planning of an innovative drug. 
 
[Study and Research]

• Research on Marketing Strategy of Innovative Generic Drugs 
• A Brief Discussion on "Direct Replacement of Usual Means" in the Review of Novelty 
• Legal Analysis of the Case of Defense but Failure with Own Patent Right 
• Top Level Design for Patent Protection 
• Discussion on Lifecycle Management Strategy of Innovative Generic Drugs 
• Litigation Strategy for Protection of Patent Rights for Methodological Invention 
• On Intellectual Property Warning Letters and Countermeasures by Case 
• Legal Approach for Patent Holder to Block Generic Drugs 
• Discussion on Intellectual Property Protection for Cross-border Drug R & D 
• Whether the presentation of products by pharmaceutical or medical device enterprises at academic meetings constitutes "promised sales" 
• Can you imitate readcavir at this stage? You are wrong! — — Viewing the Problems in the Disclosure of R & D 
• Information of Pharmaceutical Listed Companies from the Perspective of "Imitation" of Ruidcivir 
• Discussion on the transformation of scientific and technological achievements in public hospitals by medical colleges and their affiliated hospitals and the construction of air control system
Practice Areas 

News

Offices